Back to Search
Start Over
Elagolix Treatment for Up to 12 Months in Women With Heavy Menstrual Bleeding and Uterine Leiomyomas
- Source :
- Obstetrical and Gynecological Survey; September 2020, Vol. 75 Issue: 9 p545-547, 3p
- Publication Year :
- 2020
-
Abstract
- (Abstracted from Obstet Gynecol2020;135:1313–1326)Uterine leiomyomas affect up to 80% of reproductive-age women and are the most common benign neoplasm of the uterus. A variety of symptoms occur in approximately half of these women; the most common is heavy menstrual bleeding (HMB), which can result in anemia.
Details
- Language :
- English
- ISSN :
- 00297828 and 15339866
- Volume :
- 75
- Issue :
- 9
- Database :
- Supplemental Index
- Journal :
- Obstetrical and Gynecological Survey
- Publication Type :
- Periodical
- Accession number :
- ejs54306610
- Full Text :
- https://doi.org/10.1097/01.ogx.0000696612.60869.1b